
The US FDA has finalised the details of its registration scheme for pharma manufacturing facilities, which aims to make it …

An internal review of the US Food and Drug Administration has concluded that the agency needs to restructure its compliance …
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical
Claris reports visual acuity gains with experimental LSCD treatment
Amphista doses first patient in AML trial of protein degrader

